Sales decline 33.23% to Rs 4.26 crore
Net loss of Parmax Pharma reported to Rs 1.45 crore in the quarter ended March 2024 as against net profit of Rs 0.17 crore during the previous quarter ended March 2023. Sales declined 33.23% to Rs 4.26 crore in the quarter ended March 2024 as against Rs 6.38 crore during the previous quarter ended March 2023.For the full year,net loss reported to Rs 5.75 crore in the year ended March 2024 as against net loss of Rs 0.10 crore during the previous year ended March 2023. Sales declined 28.34% to Rs 11.05 crore in the year ended March 2024 as against Rs 15.42 crore during the previous year ended March 2023.
ParticularsQuarter EndedYear EndedMar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.Sales4.266.38 -33 11.0515.42 -28 OPM %-18.5413.17 --30.5914.72 - PBDT-0.940.80 PL -3.951.94 PL PBT-1.350.33 PL -5.660.06 PL NP-1.450.17 PL -5.75-0.10 -5650
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
